US 10407484
Compositions and methods for modulating T-cell mediated immune response
granted A61KA61K39/3955A61K45/06
Quick answer
US patent 10407484 (Compositions and methods for modulating T-cell mediated immune response) held by The Regents of the University of Colorado, a Body Corporate expires Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado, a Body Corporate
- Grant date
- Tue Sep 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K39/3955, A61K45/06, A61K47/68, A61K47/6937